课题基金 / 基金详情

PULMONARY INTERTITIAL DISEASE BY HAPTENS

PULMONARY INTERTITIAL DISEASE BY HAPTENS
HAPTENs 引起的肺间质疾病
批准号:
3345817
负责人:
Joan Stein-Streilein
金额:
$12.71万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-07-01 至 1991-11-30

项目摘要

项目成果

Joan Stein-Streilein的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this proposal is to study the expression of hypersensitivity in the lung using simple chemicals (2, 4, 6, trinitro-l-chlorobenzene, TNCB; Dinitrofluorobenezene, DNFB). Haptens used in the studies are similar to chemicals (trimellitic anhydride, TMA) described as industrial hazards of workers in the plastics industry. The studies are directed toward the analysis to experimental models for pulmonary interstitial disease that have been developed by the Principal Investigator. The results of these studies will have relevance for understanding mechanisms for pulmonary disease caused by industrial or environmental chemicals that react like haptens. The animals will be primed with hapten via the skin and a pulmonary response will be elicited by intratracheal inoculation of the immunizing chemical. The reactions will be assayed by histological examination of lung tissue sections, by differential analysis of cells from lung lavage, and importantly by biochemical parameters associated with other models of pulmonary interstitital fibrosis. Two pulmonary reactions have been described. An early toxic lesion as well as a late lesion demonstrating fibrotic changes was observed in (hamster) lungs 15-21 days after challenge. Pulmonary immune responses will be studied in various lymphoid compartments of the lung. The systemic immune system will be studies by quantitating specific T-lymphocytes with proliferation, and delayed type hypersensitivity and cytotoxic cell assays as well as quantitating serum antibody and specific antibody forming cells (AFC). The relationship of augmented natural killer cell activity to the pulmonary disease will be considered. The results from these studies will give new insights into the immune mechanisms that participate in the etiology of pulmonary interstitial disease. Non immune mechanisms of the experimental (hapten induced) lung disease will be determined by developing a biochemical definition of the pulmonary lesion. Preliminary studies have demonstrated an increase in total lung collagen as well as an increase in the amount of crosslinking molecules per mole of collagen in experimental hamster when compared to challenge only or normal animals. Data has also been collected that records as increase in elastin in the lungs of experimental hamsters (two weeks post challenge) compared to control animals. A biochemical analysis of this pulmonary lesion that can be induced by a severe immunological challenge in immune animals will complement the histological studies and may broaden our understanding of the development of fibrosis in the lung in general.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Ocular Immune Privilege in the Posterior Eye
  • 批准号:
    8047973
  • 项目类别:
  • 资助金额:
    $23.31万
  • 财政年份:
    2010
  • 负责人:
    Joan Stein-Streilein
  • 依托单位:
Mechanisms of Ocular Immune Privilege in the Posterior Eye
  • 批准号:
    7872399
  • 项目类别:
  • 资助金额:
    $29.29万
  • 财政年份:
    2010
  • 负责人:
    Joan Stein-Streilein
  • 依托单位:
Adaptive and innate regulation of immuneprivilege
  • 批准号:
    7388130
  • 项目类别:
  • 资助金额:
    $56.12万
  • 财政年份:
    2006
  • 负责人:
    Joan Stein-Streilein
  • 依托单位:
Adaptive and innate regulation of immuneprivilege
  • 批准号:
    7195014
  • 项目类别:
  • 资助金额:
    $48.73万
  • 财政年份:
    2006
  • 负责人:
    Joan Stein-Streilein
  • 依托单位:
国内基金
海外基金
骨胶原(Bio-Oss Collagen)联合龈下喷砂+骨皮质切开术治疗 根分叉病变的临床疗效研究
  • 批准号:
    2024JJ9542
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    潘涛华
  • 依托单位:
靶向A2BR/CollagenⅠ通路抑制循环肿瘤细胞团形成阻断肺癌转移的机制研究
  • 批准号:
    82303467
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    李青芳
  • 依托单位:
HRD1通过调控自噬介导肺纤维化肌成纤维细胞collagen-Ⅰ高分泌的机制研究
  • 批准号:
    82200080
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    刘媛媛
  • 依托单位:
Collagen VI 通过线粒体代谢/巨噬细胞调节机制调控CINP 的发生发展
  • 批准号:
    2021JJ41060
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    朱小燕
  • 依托单位: